Yunyun Chen
11Patents
1h-index
9Co-inventors
36Inventor score
Filing activity: Mar 11, 2020 → Apr 20, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10934365B2 | Anti-OX40 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11034764B2 | Anti-CTLA4 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11142582B2 | Anti-CD40 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11352429B2 | Anti-PD-1 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US12134653B2 | Anti-CD40 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11292849B2 | Anti-TNFRSF9 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11155625B2 | Anti-PD-1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11001632B2 | Anti-CTLA4 antibodies and uses thereof | General | 0 | Revoked |
| US11999790B2 | Anti-OX40 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12180281B2 | Anti-PD-1 antibodies and methods of treating cancer | Chemistry; Metallurgy | 0 | Active |
| US12054547B2 | Anti-CTLA4 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.